Short term therapeutic effect on treatment of postoperational large intestine carcinoma by fupiyiwei decoction combined with chemotherapy and it's effect on immune fuction

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 6, 2010, Pages 782-785

  Wu, Guolin ^a   Yu, Guoyou ^a   Li, Jianping ^a   Xiong, Fulin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemotherapy adverse reaction; Large intestine carcinoma; Short term clinical therapeutic; T lymphocyte subsets; Traditional Chinese medicine of fupiyiwei

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; FUPIYIWEI DECOCTION; UNCLASSIFIED DRUG;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CANCER CHEMOTHERAPY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; INCIDENCE; INTESTINE CARCINOMA; KARNOFSKY PERFORMANCE STATUS; LARGE INTESTINE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; QUALITY OF LIFE; SHORT COURSE THERAPY; THERAPY EFFECT; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NEOPLASM STAGING; PHYTOTHERAPY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 77953504220     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20100627     Document Type: Article

References (7)

1. Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment in solid tumors [J]. JNCI, 2000,92(1):205.
2. Becourn Y, Rangier P. Clinical efficacy of Oxaliplatin monotherapy:Phase 2 trials in advanced colorectal[J]. Semin Oncol, 1998, 25(2):23.